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Open access under CC BYTitanium dioxide (TiO2) is used in sunscreens and cosmetics as an ultraviolet light screen. TiO2 has car-
cinogenic activity in the rat lung, but its effect on the skin has not been reported. We examined the pro-
moting/carcinogenic effect of nano-size TiO2 particles using a two-stage skin model. c-Ha-ras proto-
oncogene transgenic (Hras128) rats, which are sensitive to skin carcinogenesis, and their wild-type sib-
lings were exposed to ultraviolet B radiation on shaved back skin twice weekly for 10 weeks; then the
shaved area was painted with a 100 mg/ml TiO2 suspension twice weekly until sacriﬁce. All rats were
killed at week 52 except for female Hras128 rats which were sacriﬁced at week 16 because of early mam-
mary tumor development. Skin tumors developed in male Hras128 rats and mammary tumors developed
in both sexes of Hras128 rats and in wild-type female rats, but tumor incidence was not different from
controls. TiO2 particles were detected in the upper stratum corneum but not in the underlying skin tissue
layers. TiO2 particles also did not penetrate a human epidermis model in vitro. Our data suggest that TiO2
does not cause skin carcinogenesis, probably due to its inability to penetrate through the epidermis and
reach underlying skin structures.
 2011 Elsevier Ltd. Open access under CC BY-NC-ND license. 1. Introduction
Titanium dioxide (TiO2) is a wide spectrum physical sunscreen
(Anderson et al., 1997) and is used in sunscreen formulations to
protect against UV radiation-related skin lesions (Gelis et al.,
2003; Rouabhia et al., 2002; Suzuki, 1987). TiO2 nanoparticles have
been introduced into sunscreen and cosmetics formulations re-
cently to improve their physical properties, e.g., make them more
transparent and less viscous, without losing their UV light blocking
ability (Newman et al., 2009). Nanoparticles, deﬁned as having at
least one dimension of 100 nm or less (ISO, 2008), were postulated
to be able to penetrate the stratum corneum and diffuse into
underlying skin structures, which gives rise to concerns about po-
tential health risks (Newman et al., 2009; Nohynek et al., 2008). Inrat, human c-Ha-ras proto-
: +81 52 836 3497.
suda).
-NC-ND license. human skin samples, topically applied tetramethylammonium
hydroxide nanoparticles and sodium bis(2-ethylhexyl) sulfosucci-
nate nanoparticles get into the hair follicles and the stratum cor-
neum and reach the viable epidermis (Baroli et al., 2007).
Dermally administrated near-infrared quantum dot nanoparticles
can localize, possibly via skin macrophages and Langerhans cells,
to regional lymph nodes (Kim et al., 2004). These ﬁndings and
the report that endothelial cells have the capacity to internalize
nanoparticles (Peters et al., 2004) suggests the possibility of poten-
tial pro-inﬂammatory, cytotoxic or other harmful effects.
TiO2 particles including micro- and nano-sized, are evaluated as
a Group 2B carcinogen by WHO/International Agency for Research
on Cancer (IARC) (Baan et al., 2006), based on 2-year animal aero-
sol inhalation studies (Lee et al., 1985; Pott and Roller, 2005). The
mechanism of lung carcinogenesis involves MIP1a derived from
TiO2-laden alveolar macrophages (Xu et al., 2010). Therefore, it is
possible that TiO2 particles may be carcinogenic to the skin and
subcutaneous tissues if they penetrate into the epidermis and
cause inﬂammatory lesions, including enhanced macrophage
Fig. 1. Schematic of the treatment schedule used to test for skin carcinogenesis in
rats. Rats were randomly allocated into three groups: Group 1: UVB radiation for
10 weeks, followed by painting with TiO2 suspension twice a week; Group 2: UVB
radiation for 10 weeks, followed by painting with the vehicle, Pentalan 408, twice a
week; and Group 3: painting with TiO2 suspension twice a week without previous
UVB radiation. (a) male Hras128 rats and male and female wild-type rats were
sacriﬁced at week 52 and (b) female Hras128 rats were sacriﬁced at week 16 due to
early mammary tumor development.
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have the ability to penetrate the stratum corneum and reach the
epidermis. Pﬂucker et al. and Mavon et al. reported that when
TiO2 particles, including micro- and nano-sizes, were topically ap-
plied repeatedly to human skin samples in vitro, only the upper
stratum corneum and hair follicles showed any evidence of particle
penetration (Mavon et al., 2007; Pﬂucker et al., 2001). Even in hu-
man skin samples after tape stripping, ultraﬁne TiO2 did not pene-
trate beyond the stratum corneum (Gottbrath and Muller-
Goymann, 2003). These results suggest that dermal penetration
of TiO2 particles is in fact associated with hair follicle oriﬁce and
not due to direct diffusion through the stratum corneum into the
epidermis. Contrary to these in vitro ﬁndings, Wu et al. reported
that TiO2 nanoparticles could penetrate through the stratum cor-
neum and be located in the deep layer of the epidermis after being
topically applied to pig ear in vivo for 30 days (Wu et al., 2009).
This study also reported that TiO2 nanoparticles reached different
tissues and induced diverse pathological lesions in several major
organs after 60 days dermal exposure to hairless mice. The differ-
ence in skin penetration between in vitro and in vivo topical appli-
cation of TiO2 particles needs further investigation.
Here, we report results of the carcinogenic effect of TiO2 parti-
cles in the skin using a UVB-initiated 2-stage carcinogenesis proto-
col. For this purpose, human c-Ha-ras proto-oncogene transgenic
rats (Hras 128) were used because they are more sensitive to
chemically induced skin carcinogens than wild-type rats (Park
et al., 2004). Our data indicate that TiO2 did not penetrate through
the epidermis and reach the underlying skin structures and did not
have skin carcinogenic activity.
2. Materials and methods
2.1. Animals
Transgenic rats carrying the human c-Ha-ras proto-oncogene (Hras128 rats),
known to be sensitive to chemically induced skin carcinogenesis in males and
mammary carcinogenesis in females, and their wild-type counterparts were main-
tained and bred by CLEA Japan Co., Ltd. (Tokyo, Japan). The animals were housed in
the Animal Center of Nagoya City University Medical School and maintained on a
12 h light/12 h dark cycle and received Oriental MF basal diet (Oriental Yeast Co.,
Tokyo, Japan) and water ad libitum. The study was conducted according to the
Guidelines for the Care and Use of Laboratory Animals of Nagoya City University
Medical School and the experimental protocol was approved by the Institutional
Animal Care and Use Committee (H17-28).
2.2. Preparation of titanium dioxide suspension
Ultraﬁne grade TiO2 particles (CAS No. 13463-67-7, rutile type, without coating,
mean primary diameter of 20 nm, Ishihara Sangyo Kaisha, Ltd., Osaka, Japan) were
provided by Japan Cosmetic Association, Tokyo, Japan. TiO2 particles were sus-
pended at 100 mg/ml in Pentalan 408 (pentaerythritol tetraethylhexanoate, CAS
7299-99-2, Nikko Chemicals Co., Tokyo, Japan). The suspensions were sonicated
for 30 min just before use, since TiO2 particles are known to form aggregates. The
size distribution of the TiO2 suspension in Pentalan 408 was analyzed by a Particle
Size Distribution Analyzer (Shimadzu Techno-Research, Inc. Kyoto, Japan.
2.3. Promotion study in the skin
A total of 80 Hras128 rats and their wild-type siblings, of both sexes and aged
10 weeks old, were randomly allocated to three groups after a 1 week acclimation:
Group 1 received ultraviolet B (UVB) radiation (UVB radiation unit, Dermaray 100,
Eisai-Toshiba, Tokyo, Japan) 2 times per week for 10 weeks at 800 mJ/cm2, 7 min,
20 cm distance from the shaved target skin, followed by painting with 0.5 ml of
TiO2 suspended in Pentalan 408 at 100 mg/ml on the shaved area twice a week until
sacriﬁce. Group 2 received UVB radiation and painting with the vehicle Pentalan
408 on the shaved area twice a week until sacriﬁce, and Group 3 received painting
with 0.5 ml of TiO2 suspension as in Group1 but without prior UVB radiation. The
painting was done gently using a bacterial spreader. The hair of the back was cut
in a 3  3 cm area with an electric clipper and the remaining hairs were thoroughly
shaved with a razor just before every UVB irradiation and/or TiO2 painting. Any
grossly visible papilloma lesions were carefully examined every day (Fig. 1). All
the animals were sacriﬁced at week 52 (after 42 weeks painting) except for the fe-
male Hras128 rats which were terminated at week 16 (after 6 weeks painting) dueto early mammary tumor development. The organs, the skin, brain, lung, liver,
mammary gland, mesenterial lymph nodes, spleen and kidney, were excised and
ﬁxed in 4% paraformaldehyde solution in PBS buffer adjusted to pH 7.3 and pro-
cessed for light microscopic examination.2.4. In vitro TiO2 penetration assay
To evaluate whether TiO2 particles could penetrate into the epidermis, the 12
well LabCyte EPI-MODEL (Japan Tissue Engineering Co., Ltd, Aichi, Japan) was used.
Eight wells were exposed to either 43.2 ll of Pentalan 408 alone or 100 or 200 mg/
ml of TiO2 suspended in Pentalan 408 for 48 h. The 24 samples in the receiving
chambers were then collected for detection of elemental titanium.2.5. Determination of the elemental titanium
For the detection of elemental titanium, 1 ml of the medium collected from the
receiving chambers was treated with 5 ml concentrated HNO3 for 22 min in a
microwave oven. Titanium in the treated solutions was determined by inductively
coupled plasma/mass spectrometry (ICP-MS) (HP-4500, Hewlett–Packard Co.,
Houston, Texas) under the following conditions: RF power-1450 W; RF refraction
current-5 W; Plasma gas current-15 L/min; Carrier gas current-0.91 L/min; Peri
pump-0.2 rps; Monitoring mass-m/z 48 (Ti); Integrating interval-0.1 s; Sampling
period 0.31 s.2.6. Cytokine analysis
Five wild-type male Sprague–Dawley rats aged 10 weeks were shaved as de-
scribed above and painted with 0.5 ml of 100 mg/ml of TiO2 suspended in Pentalan
408 on the shaved area once a day for 14 consecutive days. Five rats were painted
with Pentalan 408 as the control. The painted area was excised, rinsed with cold PBS
3 times, and homogenized in 1 ml of T-PER, Tissue Protein Extraction Reagent
(Pierce, Rockford, IL, USA), containing 1% (v/v) proteinase Inhibitor Cocktail (Sig-
ma–Aldrich, St Louis, MO, USA). The homogenates were clariﬁed by centrifugation
at 10,000g for 5 min at 4 C. Protein content was measured using a BCATM Protein
Assay Kit (Pierce). The levels of IL-1a, IL-1b, IL-6, GM-CSF, G-CFS, TNFa, IFNc, IL-
18, MCP1, MIP1a, GRO/KC, and VEGF were measured by Multiplex Suspension array
(GeneticLab, Co., Ltd., Sapporo, Japan).2.7. Statistical analysis
Statistical analysis was performed using the Kruskal–Wallis and Bonferroni/
Dunn’s multiple comparison tests. The statistical signiﬁcance was analyzed using
a two tailed Student’s t-test and the Bonferroni/Dunn’s multiple comparison tests.
A P value of <0.05 was considered to be signiﬁcant.3. Results
3.1. Size analysis of TiO2 particles
The size (diameter) of TiO2 particles suspended in Pentalan 408
ranged from 10 nm to 300 lm, with a mean size of
4.967 ± 0.500 lm and a median size of 4.570 lm, indicating that
a large majority of the original nano-size (ultraﬁne grade) TiO2 par-
ticles formed aggregates in the Pentalan 408 suspension (Fig. 2).
Fig. 2. Size distribution of TiO2 suspended in Pentalan 408. The size distribution of
TiO2 particles suspended in Pentalan 408 was analyzed by a Particle Size
Distribution Analyzer. The mean size was 4.967 ± 0.500 lm and the median size
and 4.570 lm.
Table 2
Mammary tumors in Hras128 and wild-type rats
Sex Group Treatment Incidencea Multiplicitya Weighta
(%) (No./rat) (g/rat)
Hras128
Male 1 UVB + TiO2 4/8 (50) 0.50 ± 0.53 10.50 ± 19.56
2 UVB 3/8 (36) 0.38 ± 0.51 10.17 ± 17.69
3 TiO2 4/8 (50) 0.50 ± 0.53 6.33 ± 14.16
Female 1 UVB + TiO2 5/6 (83) 1.67 ± 1.37 11.48 ± 20.61
2 UVB 2/5 (40) 0.60 ± 0.89 0.28 ± 0.53
3 TiO2 6/6 (100) 1.33 ± 0.52 4.49 ± 9.76
Wild-type
Male 1 UVB + TiO2 0/6 0 0
2 UVB 0/5 0 0
3 TiO2 0/5 0 0
Female 1 UVB + TiO2 1/8(12.5) 0.13 ± 0.35 0.63 ± 1.80
2 UVB 1/7(14.3) 0.14 ± 0.38 0.73 ± 1.93
3 TiO2 0/8(0) 0 0
a Rats died before sacriﬁce at week 52 were included.
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In male Hras128 rats, papillomas on the back skin developed
from week 32 and the incidence of skin papillomas was 1 out of
8 in Groups 1 and Group 3. No skin tumors were observed on the
targeted back skin in female Hras128 rats or wild-type rats of
either sex. Eye lid squamous cell papillomas were found in wild-
type female rats exposed to UVB (Groups 1 and 2) with incidences
of 12.5% and 14.3% (Table 1). No statistically signiﬁcant inter-group
differences in incidence, multiplicity or weight were found
(Table 1).
Mammary tumors, diagnosed as adenocarcinomas, were in-
duced with high incidence in Hras128 rats of both sexes. Wild-type
female rats also had a relatively high incidence of mammary tu-
mors compared with historical controls of spontaneous mammary
tumor development. No statistically signiﬁcant inter-group differ-
ences in incidence, multiplicity or weight were observed (Table 2).3.3. Tissue analysis of TiO2 particles
In the rat skin, no inﬂammatory lesions were observed by histo-
pathological examination. TiO2 aggregates of various sizes were
observed in the upper stratum corneum, but TiO2 was not found
in the underlying epidermis, dermis or subcutaneous tissue
(Fig. 3A). Some particles were found in the hair follicles at the levelTable 1
Skin tumors in Hras128 rats and wild-type rats
Sex Group Treatment Total No. of rats (died before termination)
Hras128
Male 1 UVB + TiO2 8 (4b)
2 UVB 8 (4b)
3 TiO2 8 (3b)
Female 1 UVB + TiO2 6
2 UVB 5
3 TiO2 6
Wild-type
Male 1 UVB + TiO2 6
2 UVB 5
3 TiO2 5
Female 1 UVB + TiO2 8 (1c,d)
2 UVB 7 (1c,1d)
3 TiO2 8
a Rats died before sacriﬁce at week 52 were included in statistic calculation of the in
b Rats died of mammary tumors between week 33 and week 51.
c Rats died of eye lid skin tumors during week 48 and week 50.
d Rats died of mammary tumors during week 48.of the granular cell layer in all the TiO2 treated groups, but not in
the deeper parts of the hair follicles or in the surrounding tissue.
In the human epidermis model, TiO2 aggregates were observed
only on the corniﬁed layer of the epidermis, but not in the epider-
mis (Fig. 3B). The amount of elemental titanium in the receiving
chamber did not show any signiﬁcant difference from the vehicle
alone group (Fig. 3C).
3.4. Cytokine analysis of the rat skin tissue
The levels of 12 inﬂammatory cytokines (IL-1a, IL-1b, IL-6, GM-
CSF, G-CFS, TNFa, IFNc, IL-18, MCP1, MIP1a, GRO/KC, and VEGF) in
the skin of rats receiving TiO2 treatment is shown in Table 3. TiO2
treatment did not have a signiﬁcant effect on the expression of the
cytokine levels in the skin compared with the vehicle group.4. Discussion
TiO2 particles, nano- and larger scale, are known to be carcino-
genic to the rat lung (Baan et al., 2006), and the mechanism of lung
carcinogenesis involves MIP1a derived from TiO2-laden alveolar
macrophages (Xu et al., 2010). Thus, they are deemed to have the
potential to cause skin tumors after long-term topical application,Survival time (mean week ± SD) Skin tumora
Incidence (%) Multiplicity (No./rat)
47.3 ± 6.8 1/8 (12.5) 0.13 ± 0.35
48.4 ± 5.5 0/8 0
48.9 ± 4.7 1/8 (12.5) 0.13 ± 0.35
16 0/6 0
16 0/5 0
16 0/6 0
52 0/6 0
52 0/5 0
52 0/5 0
51.4 ± 1.8 1/8 (12.5) 0.13 ± 0.35
51.4 ± 1.5 1/7 (14.3) 0.14 ± 0.38
52 0/8 0
cidence and multiplicity.
Fig. 3. TiO2 particles did not penetrate the epidermis. (A) TiO2 aggregates were observed in the upper stratum corneum, but were not found in the underlying epidermis,
dermis or subcutaneous tissue. (B) in the in vitro penetration assay, TiO2 aggregates were localized on the top of the human epidermis model, but not within the epidermis. (C)
the amount of elemental titanium detected in the receiving chambers is expressed as mean ± SD. A total of 24 wells of the epidermis model were exposed to the vehicle,
100 mg/ml or 200 mg/ml TiO2 suspension. Arrows indicate TiO2 aggregates.
Table 3
Expression level of 12 inﬂammatory cytokines in the skin treated with Petalan 408 or
TiO2 (5 rats in each group, ng/mg protein)
Cytokine Pentalan 408 TiO2 suspension
GM-CSF 23.65 ± 36.48 23.01 ± 16.75
G-CSF 0.37 ± 0.21 0.13 ± 0.16
IL-1a 2914 ± 433 3176 ± 785
IL-1b 38.81 ± 7.49 30.87 ± 7.26
IL-6 1.33 ± 2.97 0.00 ± 0.00
TNFa 29.56 ± 7.75 26.00 ± 8.07
INFc 5.91 ± 0.68 4.70 ± 1.10
IL-18 845 ± 234 763 ± 299
MCP-1 90 ± 125 123 ± 125
MIP-1a 3.47 ± 7.75 0.00 ± 0.00
GRO/KC 82.66 ± 21.86 63.04 ± 28.76
VEGF 17.96 ± 19.05 14.04 ± 17.55
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macrophage activity in the skin. The present study is the ﬁrst re-
port of an in vivo skin promotion/carcinogenesis study of TiO2 par-
ticles topically applied to the back skin of rats. The incidence of
skin tumors in male Hras128 was 1 out of 8 (12.5%) in the TiO2
alone group and in the UVB plus TiO2 group, higher than that of
spontaneously developed skin tumors in these rats (less than 5%)
(Park et al., 2004). However, no inter-group difference was ob-
served. Our results demonstrate that TiO2 suspension does not
have a promoting effect on skin carcinogenesis after UVB radiation.
The lack of skin carcinogenesis promotion activity is probably
due to lack of penetration of TiO2 particles through the epidermis
to the dermis, where skin tumors arise. Histologically, topically ap-
plied TiO2 particles were located only in the upper stratum cor-
neum and in some hair follicles at the level of granular cell layer,
but were not found in the epidermis or the underlying dermis.Our results are consistent with other reports (Mavon et al., 2007;
Pﬂucker et al., 2001). Furthermore, results of the in vitro skin model
assay used in our study indicate that TiO2 particles do not pene-
trate the human epidermis. Since the size of TiO2 particles was a
mixture of nano-size and micro-size, the results indicate that over-
all the particles do not penetrate through the epidermis and cause
an inﬂammatory response in the skin, although a trace amount of
nano-size particles might penetrate the skin tissue. In our study, a
large majority of the original nano-size TiO2 particles (ultraﬁne
grade) formed micro-size aggregates in the Pentalan 408 suspen-
sion and this may have affected the particle penetration. The differ-
ence between the report of Wu et al. (2009) and ours in vivo
observation may be ascribed to different test animals, different
TiO2 particles used or different methods of making the TiO2 parti-
cle suspension.
The high incidence of mammary tumors Hras128 rats regardless
of treatment is attributed to spontaneous development, which is
speciﬁc to the Hras128 rat (Asamoto et al., 2000; Matsuoka et al.,
2007; Tsuda et al., 2005).
TiO2 particle-induced lung carcinogenesis in rats is due to
chronic inﬂammation (ILSI, 2000) with the cytokine MIP1a, de-
rived from TiO2-laden alveolar macrophages, being an important
mediator of carcinogenesis (Xu et al., 2010). In the present study,
analysis of 12 inﬂammatory cytokines, IL-1a, IL-1b, IL-6, GM-CSF,
G-CFS, TNFa, IFNc, IL-18, MCP1, MIP1a, GRO/KC, and VEGF, indi-
cated that no signiﬁcant change in the expression level of these
cytokines occurred after topical application of TiO2. This result, to-
gether with histological observation, indicates that no inﬂamma-
tory reaction is evoked by topical application of TiO2. This may
partly explain why topical application of TiO2 suspension has no
carcinogenic effect in the skin.
Since tumor promotion activity is considered to be a weak car-
cinogenic activity (IARC, 1980; Ito et al., 1988, 2003; Konishi et al.,
1302 J. Xu et al. / Food and Chemical Toxicology 49 (2011) 1298–13021987; Nishikawa et al., 1994; Peraino et al., 1971; Pitot et al., 1978;
Yamanaka et al., 1996), lack of promotion activity can be inter-
preted as lack of carcinogenic activity. Thus, the results of our pres-
ent study indicate that topical application of TiO2 suspension does
not have carcinogenic activity on UVB-treated skin in rats, proba-
bly due to lack of penetration through the epidermis. In conclusion,
our results indicate that topical application of TiO2 can be consid-
ered to be safe and not carcinogenic to the skin or other organs.5. Conﬂict of Interest
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